OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

SKU Category Vector Description Price Delivery
RC210317 CDNA CLONE PS100001 MAP3K3 (Myc-DDK-tagged)-Human mitogen-activated protein kinase kinase kinase 3 (MAP3K3), transcript variant 2 $560 Immediate
RC210317L1 CDNA CLONE PS100064 Lenti ORF clone of Human mitogen-activated protein kinase kinase kinase 3 (MAP3K3), transcript variant 2 , Myc-DDK-tagged $740 Immediate
RC210317L1V CDNA CLONE PS100064 Lenti ORF particles, MAP3K3 (Myc-DDK tagged) - Human mitogen-activated protein kinase kinase kinase 3 (MAP3K3), transcript variant 2 , 200ul, >10^7 TU/mL $1140 2-3 weeks
RC210317L2 CDNA CLONE PS100071 Lenti ORF clone of Human mitogen-activated protein kinase kinase kinase 3 (MAP3K3), transcript variant 2, mGFP tagged $810 3-4 weeks
RC210317L2V CDNA CLONE PS100071 Lenti ORF particles, MAP3K3 (mGFP-tagged) - Human mitogen-activated protein kinase kinase kinase 3 (MAP3K3), transcript variant 2, 200ul, >10^7 TU/mL $1250 6-7 weeks
RG210317 CDNA CLONE PS100010 MAP3K3 (GFP-tagged) - Human mitogen-activated protein kinase kinase kinase 3 (MAP3K3), transcript variant 2 $610 Immediate
SC118669 CDNA CLONE pCMV6-XL4 MAP3K3 (untagged)-Human mitogen-activated protein kinase kinase kinase 3 (MAP3K3), transcript variant 2 NM_002401.3 $700 Immediate
SC323554 CDNA CLONE pCMV6-XL5 MAP3K3 (untagged)-Kinase deficient mutant (K422M) of Human mitogen-activated protein kinase kinase kinase 3 (MAP3K3), transcript variant 2 NM_002401.3 $700 Immediate
Still don't see what you are looking for? Try the comprehensive search
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title